Drug profile · INN
emtricitabine
DESCOVY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
emtricitabine (DESCOVY) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN emtricitabine
Brand DESCOVY
Route ORAL
Formulation CAPSULE
ATC code J05AR19
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is emtricitabine?
emtricitabine (DESCOVY) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for emtricitabine?
DESCOVY is a marketed brand name for emtricitabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of emtricitabine?
emtricitabine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.